On Wednesday, Shares of AT&T, Inc. (NYSE:T), gained 1.95% to $35.03.
AT&T, multiscreen strategy has already brought TV shows, movies, sports and news to your TV, smartphone and tablet. Now, AT&T might just bring you a new career. A new TV app called AT&T Careers, now accessible on AT&T U-verse® TV, enables jobseekers to explore AT&T career opportunities on their TV screens. The TV app is accessible to all U-verse TV customers with U-verse High Speed Internet.
AT&T Careers is an on-screen portal where jobseekers use their TV remote to discover job opportunities and learn more about what it’s like to work at AT&T. Features of the TV app comprise:
- The ability to search for jobs by keyword, location, category or map
- Video testimonials featuring current AT&T employees
- Information about employee benefits, corporate culture, diversity and employee perks
- “Email this job” button to send job postings to yourself or a friend.
AT&T Inc. provides telecommunications services in the United States and internationally. The company operates through two segments, Wireless and Wireline. The Wireless segment offers data and voice services, counting local, long-distance, and network access services, in addition to roaming services to youth, family, professionals, small businesses, government, and business customers.
Shares of Oracle Corporation (NYSE:ORCL), inclined 0.62% to $43.97, during its last trading session.
Today’s employees are mobile in and outside of the office — a challenge as companies try to integrate communications channels and tools, in addition to social media, to assist enhance productivity while managing costs. That’s the problem that Mast Mobile solves. The two-year old technology company provides an end-to-end, mobile-first, unified communications platform that assists enterprises and their employees manage business and personal data on a single device. To deliver its platform, Mast Mobile deployed Oracle Communications Billing and Revenue Administration in October 2014, enabling the start-up to define mobile policies for different groups of employees, automate split billing to distinguish between work and personal use, eliminate desk phones, and protect both company data and employee privacy.
“Mast Mobile enables a person to have multiple numbers on one device. And for that to work, we need to have a relationship with the individual, in addition to with the company,” said David Messenger, cofounder and CEO, Mast Mobile. “Our billing and rating engine had to be exceptionally flexible to allow us to correctly bill both the business account and the individual account. Oracle Communications Billing and Revenue Administration is flexible and scalable. As a start-up that regularly releases new product offerings, a dynamic billing and rating engine is a key part of our growth strategy.”
Oracle Communications Billing and Revenue Administration provides a complete solution for managing revenue and supporting business processes that incorporate generation, capture, collection, and assurance of revenue. Mast Mobile uses the solution to:
- Rate call and data session information as either a business or personal cost
- Aggregate call and data session records and deliver them in an easy-to-understand, meaningful bill to both the business and end user
- Quickly launch and bill for new services.
Oracle Corporation develops, manufactures, markets, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. It provides software and hardware systems, and related services to manage their cloud-based or on-premise IT environments, in addition to to deploy cloud software-as-a-service, platform-as-a-service, and infrastructure-as-a-service.
At the end of Wednesday’s trade, Shares of Transocean Ltd. (NYSE:RIG), lost -1.19% to $19.05, as Oil fell nearly 3 percent on Wednesday as traders and investors ignored a fifth straight weekly decline in U.S. crude stockpiles to focus instead on a big build in distillates, counting diesel, as the peak season for U.S. road travel gets under way.
U.S. crude inventories fell 1.95 million barrels last week, more than the 1.7 million forecast by analysts in a Reuters poll, a report from the government-run Energy Information Administration (EIA) showed.
Transocean Ltd., together with its auxiliaries, provides offshore contract drilling services for oil and gas wells worldwide. The company primarily offers deepwater and harsh environment drilling services.
Finally, bluebird bio, Inc. (NASDAQ:BLUE), ended its last trade with -1.96% loss, and closed at $184.77.
bluebird bio, and T cell-based immunotherapies, declared that its existing global partnership agreement with Celgene Corporation (NASDAQ: CELG) has been amended and restated to focus on developing product candidates targeting B-cell maturation antigen (BCMA) during a three-year partnership term. The original collaboration, initiated in 2013, was focused on applying gene therapy technology to genetically modify a patient’s own T cells to target and destroy cancer cells. BCMA is the first target selected to advance to the clinic under this collaboration. BCMA is a cell surface protein that is expressed in normal plasma cells and in most multiple myeloma cells, but is absent from other normal tissues.
Celgene and bluebird bio will work collaboratively on the initial, lead anti-BCMA product candidate (bb2121), with a Phase 1 clinical trial predictable to start enrollment in early 2016, and develop next-generation anti-BCMA product candidates. bluebird bio retains sole rights to develop all other chimeric antigen receptor (CAR) T cell programs developed by bluebird bio under the collaboration, counting ongoing unrevealed preclinical programs with opportunities in both solid tumors and hematologic malignancies.
Under the terms of the amended and restated partnership agreement:
- bluebird bio will receive a $25 million payment to develop the lead anti-BCMA product candidate through a Phase 1 clinical trial and develop next-generation anti-BCMA product candidates.
- bluebird bio will be responsible for the development of all anti-BCMA product candidates through the completion of Phase 1 studies.
- Additionally, on a product-by-product basis within the anti-BCMA product program, Celgene has an option to develop and commercialize each product candidate worldwide, and bluebird bio has the option to share equally in the development, promotion and profits of each product candidate in the United States. In addition to the payments described above and consistent with the preceding agreement, Celgene would also pay bluebird bio specified development and regulatory milestone payments in addition to royalty payments on net sales.
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its advanced product candidate is Lenti-D, which is in phase II/III clinical studies for the treatment of childhood cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder affecting young boys.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
